Amareswari Kadiyam, MD
Family Medicine · Tappan, NYNPI 1568871754
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,750 of the $2,731 with a category attached, or 64.1%. Gilead accounts for 70.9% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $2,557, more than ten times the $33 reported in 2019.
Across 44 payments — averaging $62.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$2K
- Pfizer$126
- GSK$111
- Novo Nordisk$95
- Lilly USA, LLC$94
- Exact Sciences$77
- plus $293 from 10 others
What the payments were for
- Consulting fees$1,75064%
- Food & beverage$98136%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 2 | $1,935 |
| Pfizer | 7 | $126 |
| GSK | 6 | $111 |
| Novo Nordisk | 5 | $95 |
| Lilly USA, LLC | 6 | $94 |
| Exact Sciences | 4 | $77 |
| Bayer | 3 | $70 |
| Boehringer Ingelheim | 3 | $64 |
| Novartis | 1 | $31 |
| Lundbeck LLC | 1 | $28 |
| Corcept Therapeutics | 1 | $24 |
| Meridian Bioscience Inc. | 1 | $19 |
| AbbVie | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$2,731 in reported general payments places this provider in the 80th percentile of 4,321 family medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 18 | $182 |
| Atorvastatin Calcium | 14 | $115 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Tappan
- Louis BonavitaEast Syracuse$674K
- Martin MahoneyBuffalo$520K
- Scott BrehautClinton$514K
- David St PeterSaratoga Springs$395K
- Matthew PabisNew York$222K
- Rajveer SachdevPomona$211K
- Eric SchnakenbergHalfmoon$190K
- James NorthGlens Falls$186K
- Eric BatesNew York$171K
- Alexander BlinskiNew York$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.